<DOC>
	<DOCNO>NCT00576342</DOCNO>
	<brief_summary>In randomize crossover study , patient receive single drop two test article assess comfort .</brief_summary>
	<brief_title>Patient Preference Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Sign inform consent ; Diagnosis glaucoma ocular hypertension ; On stable regimen intraocular pressure ( IOP ) lower medication ( monotherapy ) ; IOP , opinion investigator , participation study present risk ocular health ; Other protocoldefined inclusion criterion may apply . Best correct visual acuity bad 0.60 logMAR ( 20/80 Snellen ) either eye ; Pregnant , nursing , use highly effective birth control method ; Use oral topical corticosteroid within 30 day Screening Visit course study ; History bronchial asthma severe chronic obstructive pulmonary disease ; Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>